Effect of Pinaverium Bromide for the Treatment of Colitis in Spaniel Cocker
World Small Animal Veterinary Association World Congress Proceedings, 2007
Manuel Flores

Canine colitis is one of the most common gastrointestinal disorders. It's characterized by tenesmus, dyschezia, hematochezia and presence of mucous in feces. The most common breed affected is the Spaniel Cocker, and stress is the most common cause. The typical treatment consists of the use of metronidazole and Prednisone.

The aim of this investigation is evaluate a new drug, pinaverium bromide like an intestinal calcium channel blocker and its effect for the control of colitis in Spaniel Cocker.

Two hundred and forty two (242) dogs from natural cases were used. They were divided in two groups A and B respectively. A complete anamnesis, clinical history, physical examination and coproparasitoscopic exam was made. All the patients recorded showed tenesmus , hematochezia and mucous in feces.

The group A was treated with Metronidazole 15 mg /kg/12 hours/7 days PO and Prednisone 0.5 mg /kg/12 hours/7 days / PO. The group B was treated with pinaverium bromide 5 mg/kg/24 hours/7 days / PO. In the 7 days treatment, all the patients were fed with a hypoallergenic diet (Royal Canine).

All the patients were reviewed daily. After 7 days treatment the clinical signs in group A disappear in 3 days +/- 0.7 and in group B disappear in 2 days +/- 0.5 (p<0.01 student's test).

No clinical signs relapsed after treatment. No secondary effects were observed.

The use of pinaverium bromide appeared effective and safe for treating colitis in Spaniel Cocker.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Manuel Flores
Veterinary Hospital for Small Animals
Mexico City, Mexico


MAIN : Abstracts - Oral : Pinaverium Bromide
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27